FATE - Fate Therapeutics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - FATE (1434316)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
27 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-08-06
FATEXu YuanDirS - Sale$4.23-6338,669-7%-$2,678
2024-03-04
FATEDulac Edward J IIICFOS - Sale$7.77-2,447101,479-2%-$19,013
2024-01-29
FATEDulac Edward J IIICFOS - Sale$5.00-1,849103,926-2%-$9,245
2024-01-09
FATETahl CindyGC, SecretaryS - Sale$4.37-10,874142,361-7%-$47,519
2024-01-09
FATEValamehr BahramChief R, D OfficerS - Sale$4.38-11,271158,069-7%-$49,367
2024-01-09
FATEWolchko J ScottPres, CEOS - Sale$4.37-14,391371,248-4%-$62,889
2024-01-09
FATEDulac Edward J IIICFOS - Sale$4.37-7,028105,775-6%-$30,712
2024-01-02
FATEDulac Edward J IIICFOS - Sale$3.66-5,182112,803-4%-$18,966
2023-12-26
FATERedmile Group, LLCDir, 10%P - Purchase$3.72+44,63013,180,3880%+$166,024
2023-12-18
FATEDulac Edward J IIICFOS - Sale$3.50-1,585117,985-1%-$5,548
2023-11-09
FATETahl CindyGC, SecretaryS - Sale$2.40-24,363153,235-14%-$58,471
2023-08-18
FATEDulac Edward J IIICFOS - Sale$2.80-4,718119,570-4%-$13,210
2023-08-04
FATEXu YuanDirS - Sale$3.71-6329,302-6%-$2,345
2023-07-05
FATEPowl Brian T.Chief Commercial OfficerS - Sale$4.87-3,85441,146-9%-$18,769
2023-07-05
FATEDulac Edward J IIICFOS - Sale$4.83-5,182124,288-4%-$25,029
2023-06-14
FATEXu YuanDirS - Sale$5.58-3,4609,934-26%-$19,307
M
2023-04-20
FATERedmile Group, LLCDir, 10%P - Purchase$6.17+276,63913,135,758+2%+$1,705,829
2023-04-18
FATEChu Yu-WayeChief Medical OfficerS - Sale$6.57-2,532140,676-2%-$16,648
D
2023-04-14
FATERedmile Group, LLCDir, 10%S - Sale+OE$5.84-302,33912,859,119-2%-$1,765,660
D
2023-04-14
FATERedmile Group, LLCDir, 10%P - Purchase$6.00+25,70012,859,1190%+$154,200
M
2023-01-11
FATEMendlein JohnDirP - Purchase$5.60+124,679282,770+79%+$698,138
2023-01-10
FATEWolchko J ScottPres, CEOS - Sale$5.24-45,907385,639-11%-$240,553
2023-01-10
FATEValamehr BahramChief R, D OfficerS - Sale$5.24-10,917168,917-6%-$57,205
2023-01-10
FATETahl CindyGC, SecretaryS - Sale$5.24-11,553177,598-6%-$60,538
2023-01-10
FATEPlavsic MarkChief Technical OfficerS - Sale$5.24-3,418123,705-3%-$17,910
2023-01-10
FATEDulac Edward J IIICFOS - Sale$5.24-7,331129,470-5%-$38,414
2023-01-10
FATEChu Yu-WayeChief Medical OfficerS - Sale$5.24-7,825143,208-5%-$41,003

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top